These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4379155)

  • 1. Effect of various procedures on the repletion of cardiac catecholamine stores after tyramine.
    Bhagat B; Gilliam J
    J Pharmacol Exp Ther; 1965 Oct; 150(1):41-5. PubMed ID: 4379155
    [No Abstract]   [Full Text] [Related]  

  • 2. Interactions of bretylium and other drugs on guinea-pig atria: evidence for inhibition of neuronal monoamine oxidase by bretylium.
    Furchgott RF; Garcia PS; Wakade AR; Cervoni P
    J Pharmacol Exp Ther; 1971 Nov; 179(2):171-85. PubMed ID: 4399958
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of bretylium on amine retention in rat heart.
    Krauss KR; Kopin IJ; Weise VK
    J Pharmacol Exp Ther; 1970 Apr; 172(2):282-8. PubMed ID: 4392531
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drugs with effect on the adrenergic nerve fiber].
    Haefely W
    Pharm Acta Helv; 1968 Dec; 43(12):757-75. PubMed ID: 4886667
    [No Abstract]   [Full Text] [Related]  

  • 5. The influence of bretylium on the interactions of infused sympathomi- metic amines and tyramine in the reserpine-treated pithed rat.
    Clarke DE; Leach GD
    Br J Pharmacol Chemother; 1968 Feb; 32(2):392-401. PubMed ID: 4384657
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of drugs on uptake and release of catecholamines in the isolated left atrium of the guinea pig.
    Cervoni P; Kirpekar SM; Schwab A
    J Pharmacol Exp Ther; 1966 Feb; 151(2):196-206. PubMed ID: 5932598
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of dopamine-beta-hydroxylase by disulfiram in vivo.
    Musacchio JM; Goldstein M; Anagnoste B; Poch G; Kopin IJ
    J Pharmacol Exp Ther; 1966 Apr; 152(1):56-61. PubMed ID: 5937402
    [No Abstract]   [Full Text] [Related]  

  • 8. Restoration of tyramine responses by bretylium, BW392C60, bethanidine and monoamine oxidase inhibitors in reserpine-treated rats.
    Clarke DE
    Br J Pharmacol; 1970 Jan; 38(1):1-11. PubMed ID: 4391732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of tyramine, amphetamine and metaraminol on the metabolic disposition of 3 H-norepinephrine released from the adrenergic neuron.
    Leitz FH; Stefano FJ
    J Pharmacol Exp Ther; 1971 Sep; 178(3):464-73. PubMed ID: 4105925
    [No Abstract]   [Full Text] [Related]  

  • 10. [Noradrenaline liberating activity of orally administered tyramine and its potentiation by MAO inhibitors].
    Spano PF
    Boll Soc Ital Biol Sper; 1966 Oct; 42(20):1452-5. PubMed ID: 5972404
    [No Abstract]   [Full Text] [Related]  

  • 11. Specificity of blockade of the nicotine-induced release of 3H-norepinephrine from adrenergic neurons of the guinea-pig heart by various pharmacological agents.
    Westfall TC; Brasted M
    J Pharmacol Exp Ther; 1974 Jun; 189(3):659-64. PubMed ID: 4843166
    [No Abstract]   [Full Text] [Related]  

  • 12. The uptake and storage of H3-norepinephrine in the reserpine-pretreated rat heart.
    Iversen LL; Glowinski J; Axelrod J
    J Pharmacol Exp Ther; 1965 Nov; 150(2):173-83. PubMed ID: 4379176
    [No Abstract]   [Full Text] [Related]  

  • 13. [Inhibition of monoamine oxidase by bacteriostatically active nitrofuran derivatives].
    Palm D; Magnus U; Grobecker H; Jonsson J
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 256(2):281-300. PubMed ID: 4233003
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the pharmacology of prenylamine].
    Grobecker H; Palm D; Holtz P
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 260(5):379-99. PubMed ID: 4387688
    [No Abstract]   [Full Text] [Related]  

  • 15. The influence of sympathetic nervous activity on cardiac catecholamine levels.
    Bhagat B
    J Pharmacol Exp Ther; 1967 Jul; 157(1):74-80. PubMed ID: 4382101
    [No Abstract]   [Full Text] [Related]  

  • 16. The depletion of cardiac norepinephrine by 3,5-dihydroxy-4-methoxyphenethylamine and related compounds.
    Creveling CR; Daly JW; Witkop B
    J Pharmacol Exp Ther; 1967 Oct; 158(1):46-54. PubMed ID: 6054080
    [No Abstract]   [Full Text] [Related]  

  • 17. The accumulation of [3H]noradrenaline in the adrenergic nerve fibres of reserpine-treated mice.
    Carlsson A; Waldeck B
    J Pharm Pharmacol; 1967 Mar; 19(3):182-90. PubMed ID: 4382340
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cardiac noradrenaline and tyramine hypertension].
    Beauvallet M; Cahen R; Fugazza J; Godefroy F
    C R Seances Soc Biol Fil; 1969 Feb; 162(7):1328-31. PubMed ID: 4238879
    [No Abstract]   [Full Text] [Related]  

  • 19. Cocaine and antihistaminic compounds: comparison of effects of some cardiovascular actions of norepinephrine, tyramine and bretylium.
    Johnson GL; Kahn JB
    J Pharmacol Exp Ther; 1966 Jun; 152(3):458-68. PubMed ID: 4380726
    [No Abstract]   [Full Text] [Related]  

  • 20. Factors involved in maintenance of cardiac catecholamine content: relative importance of synthesis and re-uptake.
    Bhagat B; Friedman E
    Br J Pharmacol; 1969 Sep; 37(1):24-33. PubMed ID: 4390484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.